Skip to content
The Policy VaultThe Policy Vault

Demser — Medical Mutual

Pheochromocytoma

Initial criteria

  • The patient has tried a selective alpha blocker (e.g., doxazosin, terazosin or prazosin); AND
  • The patient has tried phenoxybenzamine (brand or generic); AND
  • Metyrosine is prescribed by, or in consultation with, an endocrinologist or a prescriber who specializes in the management of pheochromocytoma; AND
  • The patient has a surgical resection planned, has a contraindication to surgery, or has chronic malignant pheochromocytoma; AND
  • If the request is for brand Demser, the patient has tried or experienced intolerance to generic metyrosine

Reauthorization criteria

  • Patient is currently receiving metyrosine; AND
  • Metyrosine is prescribed by, or in consultation with, an endocrinologist or a prescriber who specializes in the management of pheochromocytoma; AND
  • The member’s condition has improved or stabilized while on therapy

Approval duration

initial 3 months; reauth 1 year